SAN JOSE, Calif.--(BUSINESS WIRE)--OnCore Manufacturing, LLC, a global supplier of electronic manufacturing services to medical device OEMs, today announced the opening of its first medical Center-of-Excellence (COE), located at its Fremont, California facility. Designed to meet customers’ requirements for advanced medical device design and electronic manufacturing and assembly services the facility will combine the company’s core expertise of managing highly complex medical product manufacturing and assembly with the company’s medical product design services, all cGMP compliant.
“For over twenty years the medical device market has been one of the three markets OnCore was created to serve. The company has continually enhanced the services offered our medical customers to address their evolving product lifecycle requirements. OnCore’s Medical COE makes it easier for our customers to engage the breadth of existing and expanded services by providing a ‘one-stop-shop’”, said Sajjad Malik, President and CEO of OnCore. Malik also said, “OnCore’s integrated solution has proven time and again to significantly accelerate our customers’ product innovation cycles and reduce their time-to-market.”
“The state-of-the-art COE facility provides Oraya with our own IP-secure assembly area that’s cleanroom-ready, which when coupled with OnCore’s product transfer process helps us meet our time-to-market date,” said Jim Taylor, CEO of Oraya Therapeutics. Taylor also said, “We have found OnCore very flexible in meeting Oraya’s changing requirements. This is one of the many attributes we are look for in a partner.”
OnCore Manufacturing, LLC is a leading provider of product commercialization services for low-medium volume, high-complexity products to international blue-chip aerospace and defense, industrial, and medical companies. With manufacturing facilities in Springfield and Wilmington, MA, Longmont, CO, San Marcos, Fremont and San Jose, CA, Suzhou, China and Tijuana, Mexico, OnCore manages customers’ high-complexity products while providing them maximum flexibility to manage their business in a close, collaborative relationship. More information is available at www.oncorems.com. OnCore is an equal opportunity employer.
Oraya Therapeutics, Inc. is a privately-held company developing innovative and non-invasive therapies for diseases of the eye. The company was founded in 2007. Its investors include Essex Woodlands Health Ventures, Domain Associates, Scale Venture Partners, and Synergy Life Science Partners. More information about Oraya Therapeutics can be found at www.orayainc.com.